Vertex Pharmaceuticals (BER:VX1) Price Target Increased by 10.91% to 341.78
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
The average one-year price target for Vertex Pharmaceuticals (BER:VX1) has been revised to 341.78 / share. This is an increase of 10.91% from the prior estimate of 308.16 dated April 6, 2023. The price target is an average of many targets provided by analysts.
:max_bytes(150000):strip_icc():format(jpeg)/Primary-Image-discover-bank-bonuses-february-2023-7111889-e547a5acf8354d7182211c5400da092e.jpg "Discover Bank Bonuses")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2067714497-5b2f05b3452e4f318ddd7682a7632f86.jpg "Understanding the Mutual Fund Style Box")